Pharmaceutical / Drug Definition :
Thought to inhibit sodium and chloride reabsorption from ascending loop of Henle and distal renal tubules. Increases potassium excretion and plasma volume, promoting renal excretion of water, sodium, chloride, magnesium, hydrogen, and calcium.
In the United States, Furosemide is regulated by the U.S. Food and Drug Administration (FDA). FDA has specific requirements regarding the registration and listing of Furosemide.
Registrar Corp assists Furosemide companies with:
FDA Label Requirements and Exceptions
FDA Import Information
Furosemide (Furosemide Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Furosemide (Furosemide Suppliers)
- Processors Furosemide
- Repackers Furosemide
- Relabelers Furosemide
- Exporters Furosemide
- Importers Furosemide
For more information about Furosemide, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.